Notificação de entrada na fase nacional - PCT
#1.3
07/07/2026
RPI 2896
Application data
Number
112025019259Type
Filing
Publication
PCT
EP2024056495 Examination has not been requested yet. Without that request by 03/12/2027, the application is definitively abandoned (art. 33 of the Brazilian IP Act).
Deadline to request examination:03/12/2027(199 days left)
Latest action published by the INPI: 07/07/2026. We update with every new RPI gazette, published weekly.
Applicants
ASTRAZENECA AB
SE
Inventors
P. C. (pessoa física)
GB
IPC Classification
Priority claims
EP
23161547.7 · 03/13/2023
Abstract
FORMA CRISTALINA, COMPOSIÇÃO FARMACÊUTICA, USO DA FORMA CRISTALINA, E, MÉTODO PARA IMPEDIR OU TRATAR. O presente relatório descritivo se refere a uma forma cristalina de (3S)-2-[(5-amino-6-fluoro-1H-pirrolo[3,2-b]piridin-2-il)metil]-1'-but-2-inil-6-fluoro-espiro[isoindolina-3,3'-pirrolidina]-1,2'-diona, e a composições e usos das mesmas.
Publications in the Brazilian Industrial Property Gazette (RPI).
#1.3
07/07/2026
RPI 2896
#1.1
09/23/2025
RPI 2855
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.